Goal Fusion Wealth Management, LLC Abbott Laboratories Transaction History

Goal Fusion Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 02, 2024	SELL	$90.19 - $110.4 $90,190 - $110,400	-1,000 Reduced 19.86%	4,034 $444,000
Q3 2023 Oct 10, 2023	BUY	$95.53 - $114.62 $212,172 - $254,571	2,221 Added 78.95%	5,034 $487,000
Q1 2023 Apr 03, 2023	SELL	$96.86 - $114.01 $4,068 - $4,788	-42 Reduced 1.47%	2,813 $284,000
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $271,396 - $318,389	2,855 New	2,855 $313,000

3,275

1.31B

9.63M

8.36M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $230B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Goal Fusion Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Goal Fusion Wealth Management, LLC with notifications on news.